Peter Altman - 18 May 2023 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: President and CEO, Director
Signature: /s/ David McClung, by power of attorney
Issuer symbol: BCDA
Transactions as of: 18 May 2023
Net transactions value: +$185,851
Form type: 4
Filing time: 22 May 2023, 21:30:40 UTC
Previous filing: 19 Dec 2022
Next filing: 30 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Award	$185,851	+109,324	+31%	$1.70	463,039	18 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCDA	Stock Option (right to buy)	Award	$0	+159,723		$0.000000	159,723	18 May 2023	Common Stock	159,723	$1.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on May 18, 2023.
F2	The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.